Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval By: MarketWatch February 13, 2023 at 16:55 PM EST Madrigal Pharmaceuticals' resmetirom is a leading treatment candidate for the advanced form of fatty liver disease. Read More >> Related Stocks: 89Bio Inc Eli Lilly Genfit S.A. ADR Intercept Pharmaceuticals Madrigal Pharmaceuticals Inc Ngm Biopharmaceuticals Inc Terns Pharmaceuticals Inc Viking Thera Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Inside the NASH drug boom: New drugs for a ‘silent’ liver disease that affects millions near FDA approval By: MarketWatch February 13, 2023 at 16:55 PM EST Madrigal Pharmaceuticals' resmetirom is a leading treatment candidate for the advanced form of fatty liver disease. Read More >> Related Stocks: 89Bio Inc Eli Lilly Genfit S.A. ADR Intercept Pharmaceuticals Madrigal Pharmaceuticals Inc Ngm Biopharmaceuticals Inc Terns Pharmaceuticals Inc Viking Thera